Johnson & Johnson (NYSE:JNJ) CEO Joaquin Duato says the company isn’t harping on mergers and acquisitions as it grows its MedTech business. Speaking on the company’s second-quarter earnings call, Duato emphasized that Johnson & Johnson MedTech, its rebranded medical devices business, has its sights set on strengthening current strongholds and accessing high-growth market segments to […]
Johnson & Johnson
Johnson & Johnson beats The Street in Q2, lowers full-year guidance
Johnson & Johnson (NYSE:JNJ) shares were up before hours on second-quarter results that came in ahead of the consensus forecast. The New Brunswick, New Jersey-based company posted profits of $4.8 billion, or $1.80 per share, on sales of $24 billion for the quarter ended June 2022, for a 23.3% bottom-line slide on sales growth of […]
J&J EVP, general counsel Michael Ullmann set to retire
Johnson & Johnson (NYSE:JNJ) announced today that, after 33 years, Michael Ullmann will retire as EVP and general counsel. Ullmann’s retirement will be made effective on Oct. 17, 2022, at which point Elizabeth Forminard will succeed him as EVP and general counsel, as well as take up a position as a member of Johnson & […]
Moon Surgical raises $31.3M for robotic surgery system
Moon Surgical (Paris and San Francisco) announced today that it has raised $31.3 million in Series A funding to expand its team and accelerate the development of its Maestro robotic surgery system. GT Healthcare Capital & Partners led the round. There was also participation from Johnson & Johnson Innovation – JJDC, Cathay Health — and […]
Ethicon launches next-gen surgical stapler
Johnson & Johnson’s Ethicon today announced the U.S. launch of its next-gen Echelon 3000 stapler. The Echelon 3000 is digitally-enabled and provides surgeons with simple, one-handed powered articulation, according to the Johnson & Johnson (NYSE:JNJ) company. The surgical stapler’s creators designed it with 39% greater jaw aperture and a 27% greater articulation span. The idea […]
FDA clears DePuy Synthes’ Inhance for total shoulder arthroplasty
Johnson & Johnson MedTech’s DePuy Synthes ortho device company announced today that its Inhance system has received FDA clearance for total shoulder arthroplasty. DePuy Synthes officials say their company is first to market with a fully convertible should arthroplasty system. The new clearance is in addition to the system’s already cleared use in anatomic shoulder […]
Johnson & Johnson’s Consumer Health chief to run new stand-alone company
Thibaut Mongon — EVP and Worldwide Chair of Consumer Health at Johnson & Johnson since 2019 — will be CEO of the business when it spins out as a stand-alone company. J&J (NYSE: JNJ) expects the spinoff to be complete in 2023, subject to legal requirements, including consultation with works councils and employee representatives. “Thibaut […]
Johnson & Johnson MedTech appoints new CFO
Johnson & Johnson MedTech (NYSE:JNJ) announced that Kurt Van den Bosch has been appointed as its CFO, group finance. Van den Bosch will be a member of Johnson & Johnson’s global finance team, reporting to the company’s EVP and CFO Joe Wolk. Van den Bosch’s role includes providing financial leadership to the global Johnson & […]
The cloud is transforming medtech: Amazon, Microsoft, Google, J&J, Philips and GE Healthcare leaders explain
Leaders in medtech and cloud computing discuss payoffs and potential in device connectivity, product development and cross-industry partnerships. If knowledge is power, that power comes from a steady stream of information, and we know there’s no shortage of that in healthcare. The challenge has long been how to capture that information, store it, analyze it […]
Manufacturing matchmaker Fictiv raises $100M for supply chain push
Fictiv has closed a $100 million Series E funding round, the on-demand manufacturing technology company said today. Fictiv focuses on “helping companies produce better products,” co-founder and CEO Dave Evans said, with three main offerings: new product development, engineer-to-order products, and maintenance, repair and operations (MRO). But the company doesn’t actually own any manufacturing equipment. […]
Johnson & Johnson Vision wins Fast Company award for drug-eluting contact lens
Johnson & Johnson Vision announced today that it was named a winner of Fast Company’s 2022 World Changing Ideas Awards. The eye health business arm of Johnson & Johnson (NYSE: JNJ) received the award in the “Wellness” category for its Acuvue Theravision with ketotifen (etafilcon A drug-eluting contact lens with ketotifen). The drug-eluting contact, which provides a new wearing experience […]